Correlation Between Plandai Biotech and Santeon

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Plandai Biotech and Santeon at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Plandai Biotech and Santeon into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Plandai Biotech and Santeon Group, you can compare the effects of market volatilities on Plandai Biotech and Santeon and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Plandai Biotech with a short position of Santeon. Check out your portfolio center. Please also check ongoing floating volatility patterns of Plandai Biotech and Santeon.

Diversification Opportunities for Plandai Biotech and Santeon

-0.12
  Correlation Coefficient

Good diversification

The 3 months correlation between Plandai and Santeon is -0.12. Overlapping area represents the amount of risk that can be diversified away by holding Plandai Biotech and Santeon Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Santeon Group and Plandai Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Plandai Biotech are associated (or correlated) with Santeon. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Santeon Group has no effect on the direction of Plandai Biotech i.e., Plandai Biotech and Santeon go up and down completely randomly.

Pair Corralation between Plandai Biotech and Santeon

Given the investment horizon of 90 days Plandai Biotech is expected to generate 2.57 times more return on investment than Santeon. However, Plandai Biotech is 2.57 times more volatile than Santeon Group. It trades about 0.15 of its potential returns per unit of risk. Santeon Group is currently generating about 0.09 per unit of risk. If you would invest  0.03  in Plandai Biotech on September 4, 2024 and sell it today you would lose (0.02) from holding Plandai Biotech or give up 66.67% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy99.6%
ValuesDaily Returns

Plandai Biotech  vs.  Santeon Group

 Performance 
       Timeline  
Plandai Biotech 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Plandai Biotech are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite quite weak basic indicators, Plandai Biotech disclosed solid returns over the last few months and may actually be approaching a breakup point.
Santeon Group 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Santeon Group are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively inconsistent basic indicators, Santeon unveiled solid returns over the last few months and may actually be approaching a breakup point.

Plandai Biotech and Santeon Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Plandai Biotech and Santeon

The main advantage of trading using opposite Plandai Biotech and Santeon positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Plandai Biotech position performs unexpectedly, Santeon can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Santeon will offset losses from the drop in Santeon's long position.
The idea behind Plandai Biotech and Santeon Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities